Low-level genomic instability is a feature of papillary thyroid carcinoma: An array comparative genomic hybridization study of laser capture microdissected papillary thyroid carcinoma tumors and clonal cell lines

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 1, 2007, Pages 65-73

  Finn, Stephen ^a   Smyth, Paul ^b   O'Regan, Esther ^c   Cahill, Suzanne ^b   Toner, Mary ^c   Timon, Conrad ^b   Flavin, Richard ^b   O'Leary, John ^b   Sheils, Orla ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b ST JAMES S HOSPITAL   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; PLATELET DERIVED GROWTH FACTOR B; PROTEIN PATCHED; PROTEIN RET;

ADULT; AGED; ARTICLE; CELL CLONE; CELL CULTURE; CELL LINE; CELL POPULATION; CHROMOSOMAL INSTABILITY; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 15; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 19; CHROMOSOME 22; CHROMOSOME 4; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSTIC PROCEDURE; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MALE; MICROARRAY ANALYSIS; MOLECULAR CLONING; MORPHOLOGY; PREVALENCE; THYROID PAPILLARY CARCINOMA;

ADULT; AGED; AUTOANTIGENS; CARCINOMA, PAPILLARY; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENE DOSAGE; GENOMIC INSTABILITY; HUMANS; LASERS; MALE; MICRODISSECTION; MIDDLE AGED; NUCLEAR PROTEINS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RET; PROTO-ONCOGENE PROTEINS C-SIS; RIBONUCLEOPROTEINS, SMALL NUCLEAR; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 33846647338     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Johannessen JV, Sobrinho-Simoes M, Tangen KO, Lindmo T. A flow cytometric deoxyribonucleic acid analysis of papillary thyroid carcinoma. Lab Invest. 1981;45:336-341.
2. Soares P, dos Santos NR, Seruca R, Lothe RA, Sobrinho-Simoes M. Benign and malignant thyroid lesions show instability at microsatellite loci. Eur J Cancer. 1997;33:293-296.
3. Kitamura Y, Shimizu K, Tanaka S, Ito K, Emi M. Association of allelic loss on 1q, 4p, 7q, 9p, 9q, and 16q with postoperative death in papillary thyroid carcinoma. Clin Cancer Res. 2000;6:1819-1825.
4. Gillespie JW, Nasir A, Kaiser HE. Loss of heterozygosity in papillary and follicular thyroid carcinoma: a mini review. In Vivo. 2000;14:139-140.
5. Namba H, Rubin SA, Fagin JA. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol Endocrinol. 1990;4:1474-1479.
6. Puxeddu E, Moretti S, Elisei R, et al. BRAF (V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. J Clin Endocrinol Metab. 2004;89:2414-2420.
7. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signalling pathway in papillary thyroid carcinoma. Cancer Res. 2003;63:1454-1457.
8. Soares P, Trovisco V, Rocha AS, et al. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene. 2003;22:4578-4580.
9. Smyth P, Finn SP, Cahill S, et al. Ret/PTC and BRAF act as distinct molecular time dependent triggers in a sporadic cohort of papillary thyroid carcinoma. Int J Surg Pathol. 2005;13:1-8.
10. Nikiforova MN, Ciampi R, Salvatore G, et al. Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer Lett. 2004;209:1-6.
11. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992;258: 818-821.
12. Kallioniemi A, Kallioniemi OP, Piper J, et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A. 1994;91:2156-2160.
13. Bentz M, Plesch A, Stilgenbauer S, Dohner H, Lichter P. Minimal sizes of deletions detected by comparative genomic hybridisation. Genes Chromosomes Cancer. 1992;2:172-175.
14. Joos S, Scherthan H, Speicher MR, Schlegel J, Cremer T, Lichter P. Detection of amplified DNA sequences by reverse chromosome painting using genomic tumor DNA as probe. Hum Genet. 1993;90:584-589.
15. Piper J, Rutovitz D, Sudar D, et al. Computer image analysis of comparative genomic hybridisation. Cytometry. 1995;19:10-26.
16. Pinkel D, Segraves R, Sudar D, et al. High-resolution analysis of DNA copy number variation using comparative genomic hybridisation to microarrays. Nat Genet. 1998;20:207-211.
17. O'Regan EM, Toner ME, Smyth PC, et al. Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patients. Head Neck. 2006;28:330-338.
18. Finn SP, Smyth P, O'Regan EM, et al. Array CGH analysis of gamma irradiated human thyrocytes. Virchows Arch. 2004;445:396-404.
19. Finn SP, Smyth P, O'Leary JJ, Sweeney EC, Sheils OM. Ret/PTC chimeric transcripts in an Irish cohort of sporadic papillary thyroid carcinoma. J Clin Endocrinol Metab. 2003;88:938-941.
20. Albrecht B, Hausmann M, Zitzelsberger H, et al. Array-based comparative genomic hybridisation for the detection of DNA sequence copy number changes in Barrett's adenocarcinoma. J Pathol. 2004;203:780-788.
21. Schraml P, Schwerdtfeger G, Burkhalter F, et al. Combined array comparative genomic hybridisation and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol. 2003;163:985-992.
22. Hui AB, Lo KW, Yin XL, Poon WS, Ng HK. Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridisation. Lab Invest. 2001;81:717-723.
23. Pierotti MA, Bongarzone I, Borello MG, Greco A, Pilotti S, Suzy G. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells. Genes Chromosomes Cancer. 1996;16:1-14.
24. Ward LS, Brenta G, Medvedovic M, Fagin JA. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. J Clin Endocrinol Metab. 1998;83:525-530.
25. Herrmann M, Hay ID, Bartelt DH Jr, et al. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J Clin Invest. 1991;88: 1596-1604.
26. Califano JA, Johns MM III, Westra WH, et al. An allelotype of papillary thyroid cancer. Int J Cancer 1996;69:442-444.
27. Chen X, Knauf JA, Gonsky R, Wang M, Lai EH, Chissoe S. From amplification to gene in thyroid cancer: a high resolution mapped bacterial-artificial- chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genomic hybridisation. Am J Hum Genet. 1998;63:625-637.
28. Singh B, Lim D, Cigudosa JC, et al. Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridisation. Surgery. 2000;128:888-894.
29. Hemmer S, Wasenius VM, Knuutila S, Franssila K, Joensuu H. DNA copy number changes in thyroid carcinoma. Am J Pathol. 1999;154:1539-1547.
30. Kjellman P, Lagercrantz S, Hoog A, Wallin G, Larsson C, Zedenius J. Gain of 1q and loss of 9q21.3.q32 are associated with a less favourable prognosis in PTC. Genes Chromosomes Cancer. 2001;32:43-49.
31. Bauer AJ, Cavalli LR, Rone JD, et al. Evaluation of adult papillary thyroid carcinomas by comparative genomic hybridisation and microsatellite instability analysis. Cancer Genet Cytogenet. 2002;135:182-186.
32. Yano Y, Uematsu N, Yashiro T, et al. Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma. Clin Cancer Res. 2004;10:2035-2043.